articleNature BiotechnologyAug 26, 2007Closed access

Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors

MBMarcus BantscheffDEDirk EberhardYAYann AbrahamSBSonja BastuckMBMarkus Böesche

CellCentric (United Kingdom)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,043
total citations
FWCI
32.16
Percentile
100%
References
51
Citations per year

Authors

21

Topics & keywords

Topics
Keywords
  • Dasatinib
  • Kinase
  • Proteome
  • Proteomics
  • Drug discovery
  • Tyrosine kinase
  • Imatinib
  • Chemistry
UN Sustainable Development Goals
  • Zero hunger
No related works found for this paper.